Pat Albert Fetaya

Pat Albert Fetaya Email and Phone Number

BIOTECH BUSINESS DEVELOPMENT | COMMERCIAL ASSESSMENT | STRATEGY @ Servier Pharmaceuticals
Pat Albert Fetaya's Location
New York City Metropolitan Area, United States, United States
Pat Albert Fetaya's Contact Details
About Pat Albert Fetaya

CORPORATE DEVELOPMENT | COMMERCIAL ASSESSMENT | STRATEGYDiverse corporate development leader with deep and extensive track record in the pharmaceutical, medical device, and technology sectors. Leverage of positions held in corporate development, marketing, engineering, and sales, across a background in Fortune 50 and start-up organizations, to develop and execute strategies and transactions that drive business growth. As deal professional, have initiated, led, and completed numerous licensing, acquisition, venture, and marketing transactions which consistently exceeded their strategic and financial objectives. In marketing strategy role, recognized with numerous awards including BMS President’s Award. Experiences in VC funded start-ups have provided insightful and unique perspectives on successfully identifying and driving new growth concepts, while in roles in large multi-national firms have developed ability to collaborate across the matrix and drive consensus to maximize value of broad corporate initiatives. VC fund liaison for corporate limited partner VC fund investments and board advisor to VC fund start ups.Committed to working collaboratively, driving teamwork and alignment in leading cross-functional teams, and promoting engagement and development among peers.

Pat Albert Fetaya's Current Company Details
Servier Pharmaceuticals

Servier Pharmaceuticals

View
BIOTECH BUSINESS DEVELOPMENT | COMMERCIAL ASSESSMENT | STRATEGY
Pat Albert Fetaya Work Experience Details
  • Servier Pharmaceuticals
    Head, Us Business Development
    Servier Pharmaceuticals Oct 2021 - Present
    Boston , Ma , Us
    Shape and lead the US business development function for Servier, a $5.4 billion revenue EU based firm broadening its commercial presence by focusing on portfolio expansion in oncology.Accountability includes strategy development, commercial assessments, and transactions. Position reports directly to US Chief Business Officer, secondarily to EU based Global Business Development team.
    View
  • Save
    Board Member
    Save Sep 2022 - Present
    Founded in 1941, SAVE is an independent 501(c)(3) non-profit animal shelter dedicated to protecting the health and welfare of homeless companion animals in the greater Princeton area. Through six core programs of Rescue, Shelter, Health and Welfare, Spay/Neuter, Adoption, and Humane Education, SAVE focuses on the rehabilitation and successful placement of treatable and adoptable animals. SAVE endeavors to build, foster, and strengthen the human-animal bond.
  • Sun Pharma
    Senior Director, Business Development And Strategy, Us Specialty Pharma
    Sun Pharma Jul 2019 - Oct 2021
    Mumbai, Maharastra, In
    Joint reporting to Global Vice President Business Development and North American CEO. Lead business development function for Sun's US Specialty Pharma business, including oncology, ophthalmology, and dermatology business units. Accountabilities include transactions, commercial assessments, and VC fund limited partnerships investments.
    View
  • Sun Pharma
    Director, Business Development And Strategy, Us Specialty Pharm
    Sun Pharma Aug 2017 - Jun 2019
    Mumbai, Maharastra, In
    Reporting to NA CEO, member of team charged with building a new specialty pharma business unit for Sun, a $5 Billion global revenue firm historically focused on generics.Transactional and commercial assessment role with accountabilities spanning full range of business development activities, including negotiation, contracting, deal sourcing, deal structurng, forecasting, and valuation, Manage multiple Limited Partner VC Fund investments. Successfully led transactions and commercial assessments across Oncology, Dermatology, Ophthalmology, and CNS therapeutics areas.
    View
  • Sun Pharma
    Director, Portfolio Strategy And Development, Us Specialty Pharm
    Sun Pharma Mar 2016 - Jul 2017
    Mumbai, Maharastra, In
    Commercial assessment, forecasting, and business case development for business development and internal development projects across Sun's dermatology and oncology business units.
    View
  • Bristol-Myers Squibb
    Director | Global Commercialization
    Bristol-Myers Squibb 2012 - 2015
    Lawrence Township, Nj, Us
    Marketing strategy group with accountability across CV, oncology, virology, and immunoscience therapeutic areas for diverse initiatives spanning strategic planning, operational model design, commercial effectiveness, and innovation.*Key role in enterprise transformation of operational model for transition of prelaunch assets from global to market brand teams.  *Designed integrated global and market asset level strategy and functional planning processes to maximize launch effectiveness and accelerate speed to patient.*Led firm wide assessment of global and market needs for digital marketing, leading to strategy outlining digital solutions and organizational accountability.*Re-engineered firm wide standard launch planning toolkit, including baseline content and collaboration methodology, subsequently adopted as common approach by all pre-launch asset teams.*Developed formal Prioritization Framework utilized by senior leadership in strategic planning to drive resource allocation decisions in 2014 budget cycle. *Led initiative to assess company’s worldwide commercial innovation portfolio and develop recommendations to accelerate future innovation outcomes.Recipient of seven formal performance excellence recognition awards during time in role.
    View
  • Johnson & Johnson
    Associate Director | New Business Development
    Johnson & Johnson 2004 - 2011
    New Brunswick, Nj, Us
    Accountable for strategy development and transaction leadership of externally sourced new revenue growth opportunities based on development stage and marketed healthcare technologies. Work scope included market research, commercial assessments, leadership reviews, cross-functional team management, diligence, document prep, structuring, negotiation, and integration planning. Managed MBAs and mentored junior staff members
    View
  • Avaya
    Director | Corporate Development
    Avaya 2001 - 2003
    Morristown, New Jersey, Us
    Enterprise applications and services firm with $8 Billion in revenues. Responsible for strategic, financial, and implementation assessments of business development opportunities. Led project teams and executed critical activities to structure, negotiate, and close targeted deals.
    View
  • Newview Technologies Inc | Kleiner Perkins Portfolio Firm
    Director | Business Development
    Newview Technologies Inc | Kleiner Perkins Portfolio Firm 2000 - 2001
    Menlo Park, Ca, Us
    Start up which raised $100 million in capital to develop and provide marketplace, private exchange, and supply chain solutions for direct materials. Role included assessment of marketing partnerships, development and management of strategic alliances, and technology partnerships selections.
    View
  • Sri International
    Director | Business Development
    Sri International 1998 - 2000
    Menlo Park, Ca, Us
    Initiatives supporting strategy of growth through patent licensing and new ventures in healthcare, electronics, and IT marketplaces. Assessed technology commercialization opportunities, developed start up business plans, and pursued funding from institutional VC funds.
    View

Pat Albert Fetaya Skills

Cross Functional Team Leadership Strategy Medical Devices Management Pharmaceutical Industry Start Ups Business Development Mergers And Acquisitions Commercialization Strategic Planning Leadership Competitive Analysis Negotiation Strategic Partnerships New Business Development Corporate Development Analytics Mergers Forecasting Licensing Due Diligence Pharmaceuticals Product Launch Technology Evaluation Valuation Financial Modeling Strategy Development Project Management Management Consulting Marketing Strategy Market Research Biotechnology Marketing Oncology

Pat Albert Fetaya Education Details

  • University Of Pennsylvania
    University Of Pennsylvania
    Engineering/Business
  • Rutgers Business School
    Rutgers Business School
    Mba | Finance
  • The City University Of New York
    The City University Of New York
    Queens College | Ba | Chemistry
  • Rutgers Business School
    Rutgers Business School
    Mini-Mba | Digital Marketing

Frequently Asked Questions about Pat Albert Fetaya

What company does Pat Albert Fetaya work for?

Pat Albert Fetaya works for Servier Pharmaceuticals

What is Pat Albert Fetaya's role at the current company?

Pat Albert Fetaya's current role is BIOTECH BUSINESS DEVELOPMENT | COMMERCIAL ASSESSMENT | STRATEGY.

What is Pat Albert Fetaya's email address?

Pat Albert Fetaya's email address is pf****@****pcb.com

What is Pat Albert Fetaya's direct phone number?

Pat Albert Fetaya's direct phone number is +190835*****

What schools did Pat Albert Fetaya attend?

Pat Albert Fetaya attended University Of Pennsylvania, Rutgers Business School, The City University Of New York, Rutgers Business School.

What skills is Pat Albert Fetaya known for?

Pat Albert Fetaya has skills like Cross Functional Team Leadership, Strategy, Medical Devices, Management, Pharmaceutical Industry, Start Ups, Business Development, Mergers And Acquisitions, Commercialization, Strategic Planning, Leadership, Competitive Analysis.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.